Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
VIP (Vasoactive Intestinal Peptide) Peptide
Neuropeptide researched for immune modulation and lung protection.
What is VIP (Vasoactive Intestinal Peptide)?
VIP (Vasoactive Intestinal Peptide) is a immune · respiratory peptide studied for acute respiratory distress syndrome (ards) and chronic inflammatory conditions. Below is an educational overview of VIP (Vasoactive Intestinal Peptide) peptide benefits, mechanism, common research protocols, dosage references, and known side effects.
VIP (Vasoactive Intestinal Peptide) Mechanism of Action
A 28-amino-acid neuropeptide with broad immunomodulatory, anti-inflammatory, and bronchodilatory effects. Acts via VPAC1 and VPAC2 receptors to regulate T-cell function, macrophage polarization, and airway smooth muscle tone.
VIP (Vasoactive Intestinal Peptide) Research Areas & Benefits
VIP (Vasoactive Intestinal Peptide) Dosage & Common Research Protocols
Inhalation for pulmonary indications; IV for systemic immune modulation.
Protocols summarized for educational reference from published research. Not dosing guidance.
VIP (Vasoactive Intestinal Peptide) Studies & Cited Research
VIP in acute respiratory distress syndrome
Demonstrated lung-protective effects in preclinical ARDS models.
Why we trust this source: Published in a peer-reviewed scientific journal with editorial and reviewer oversight.
VIP and immune tolerance
Reviewed mechanisms of T-regulatory cell induction and immune homeostasis.
Why we trust this source: Published in a peer-reviewed scientific journal with editorial and reviewer oversight.
Citations are linked to PubMed, Google Scholar, and Crossref searches so you can verify the source independently. All references are reviewed during our editorial passes (last reviewed June 1, 2026).
VIP (Vasoactive Intestinal Peptide) Side Effects & Safety Considerations
- •Short half-life limits therapeutic utility; analogs in development.
- •Not FDA-approved in native form.
Common questions about VIP (Vasoactive Intestinal Peptide)
More Immune peptides · See all 6
Educational Information Only — Not Medical Advice
All content on this page is for educational and informational purposes only. It is not medical advice, diagnosis, or treatment. We make no claims that any peptide can diagnose, treat, cure, or prevent any disease. Peptides discussed are not FDA-approved for the indications listed unless explicitly stated otherwise.
Always consult a licensed healthcare provider before beginning any wellness protocol. Statements have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability, eligibility, and pricing may vary.
Ask the Library
Ask anything about peptides — answers come from our curated reference library with citations.